Hero Background

Facial Rejuvenation Market

ID: MRFR/HC/7339-HCR
90 Pages
Satyendra Maurya
Last Updated: May 15, 2026
Facial Rejuvenation Market Research Report By Treatment Type (Surgical Procedures, Non-Surgical Procedures, Injectables, Laser Treatments), By Procedure Category (Facelift, Botox Injections, Dermal Fillers, Chemical Peels), By Skin Type (Aging Skin, Dry Skin, Oily Skin, Combination Skin), By Target Group (Men, Women, Aging Population) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth & Industry Forecast 2025 To 2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Healthcare, BY Treatment Type (USD Billion)
      1. 4.1.1 Surgical Procedures
      2. 4.1.2 Non-Surgical Procedures
      3. 4.1.3 Injectables
      4. 4.1.4 Laser Treatments
    2. 4.2 Healthcare, BY Procedure Category (USD Billion)
      1. 4.2.1 Facelift
      2. 4.2.2 Botox Injections
      3. 4.2.3 Dermal Fillers
      4. 4.2.4 Chemical Peels
    3. 4.3 Healthcare, BY Skin Type (USD Billion)
      1. 4.3.1 Aging Skin
      2. 4.3.2 Dry Skin
      3. 4.3.3 Oily Skin
      4. 4.3.4 Combination Skin
    4. 4.4 Healthcare, BY Target Group (USD Billion)
      1. 4.4.1 Men
      2. 4.4.2 Women
      3. 4.4.3 Aging Population
    5. 4.5 Healthcare, BY Region (USD Billion)
      1. 4.5.1 North America
        1. 4.5.1.1 US
        2. 4.5.1.2 Canada
      2. 4.5.2 Europe
        1. 4.5.2.1 Germany
        2. 4.5.2.2 UK
        3. 4.5.2.3 France
        4. 4.5.2.4 Russia
        5. 4.5.2.5 Italy
        6. 4.5.2.6 Spain
        7. 4.5.2.7 Rest of Europe
      3. 4.5.3 APAC
        1. 4.5.3.1 China
        2. 4.5.3.2 India
        3. 4.5.3.3 Japan
        4. 4.5.3.4 South Korea
        5. 4.5.3.5 Malaysia
        6. 4.5.3.6 Thailand
        7. 4.5.3.7 Indonesia
        8. 4.5.3.8 Rest of APAC
      4. 4.5.4 South America
        1. 4.5.4.1 Brazil
        2. 4.5.4.2 Mexico
        3. 4.5.4.3 Argentina
        4. 4.5.4.4 Rest of South America
      5. 4.5.5 MEA
        1. 4.5.5.1 GCC Countries
        2. 4.5.5.2 South Africa
        3. 4.5.5.3 Rest of MEA
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Healthcare
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Allergan (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Revance Therapeutics (US)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Medytox (KR)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Galderma (CH)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Ipsen (FR)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Hugel (KR)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Medytox (KR)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Sientra (US)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
      9. 5.2.9 Hugel (KR)
        1. 5.2.9.1 Financial Overview
        2. 5.2.9.2 Products Offered
        3. 5.2.9.3 Key Developments
        4. 5.2.9.4 SWOT Analysis
        5. 5.2.9.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 NORTH AMERICA MARKET ANALYSIS
    3. 6.3 US MARKET ANALYSIS BY TREATMENT TYPE
    4. 6.4 US MARKET ANALYSIS BY PROCEDURE CATEGORY
    5. 6.5 US MARKET ANALYSIS BY SKIN TYPE
    6. 6.6 US MARKET ANALYSIS BY TARGET GROUP
    7. 6.7 CANADA MARKET ANALYSIS BY TREATMENT TYPE
    8. 6.8 CANADA MARKET ANALYSIS BY PROCEDURE CATEGORY
    9. 6.9 CANADA MARKET ANALYSIS BY SKIN TYPE
    10. 6.10 CANADA MARKET ANALYSIS BY TARGET GROUP
    11. 6.11 EUROPE MARKET ANALYSIS
    12. 6.12 GERMANY MARKET ANALYSIS BY TREATMENT TYPE
    13. 6.13 GERMANY MARKET ANALYSIS BY PROCEDURE CATEGORY
    14. 6.14 GERMANY MARKET ANALYSIS BY SKIN TYPE
    15. 6.15 GERMANY MARKET ANALYSIS BY TARGET GROUP
    16. 6.16 UK MARKET ANALYSIS BY TREATMENT TYPE
    17. 6.17 UK MARKET ANALYSIS BY PROCEDURE CATEGORY
    18. 6.18 UK MARKET ANALYSIS BY SKIN TYPE
    19. 6.19 UK MARKET ANALYSIS BY TARGET GROUP
    20. 6.20 FRANCE MARKET ANALYSIS BY TREATMENT TYPE
    21. 6.21 FRANCE MARKET ANALYSIS BY PROCEDURE CATEGORY
    22. 6.22 FRANCE MARKET ANALYSIS BY SKIN TYPE
    23. 6.23 FRANCE MARKET ANALYSIS BY TARGET GROUP
    24. 6.24 RUSSIA MARKET ANALYSIS BY TREATMENT TYPE
    25. 6.25 RUSSIA MARKET ANALYSIS BY PROCEDURE CATEGORY
    26. 6.26 RUSSIA MARKET ANALYSIS BY SKIN TYPE
    27. 6.27 RUSSIA MARKET ANALYSIS BY TARGET GROUP
    28. 6.28 ITALY MARKET ANALYSIS BY TREATMENT TYPE
    29. 6.29 ITALY MARKET ANALYSIS BY PROCEDURE CATEGORY
    30. 6.30 ITALY MARKET ANALYSIS BY SKIN TYPE
    31. 6.31 ITALY MARKET ANALYSIS BY TARGET GROUP
    32. 6.32 SPAIN MARKET ANALYSIS BY TREATMENT TYPE
    33. 6.33 SPAIN MARKET ANALYSIS BY PROCEDURE CATEGORY
    34. 6.34 SPAIN MARKET ANALYSIS BY SKIN TYPE
    35. 6.35 SPAIN MARKET ANALYSIS BY TARGET GROUP
    36. 6.36 REST OF EUROPE MARKET ANALYSIS BY TREATMENT TYPE
    37. 6.37 REST OF EUROPE MARKET ANALYSIS BY PROCEDURE CATEGORY
    38. 6.38 REST OF EUROPE MARKET ANALYSIS BY SKIN TYPE
    39. 6.39 REST OF EUROPE MARKET ANALYSIS BY TARGET GROUP
    40. 6.40 APAC MARKET ANALYSIS
    41. 6.41 CHINA MARKET ANALYSIS BY TREATMENT TYPE
    42. 6.42 CHINA MARKET ANALYSIS BY PROCEDURE CATEGORY
    43. 6.43 CHINA MARKET ANALYSIS BY SKIN TYPE
    44. 6.44 CHINA MARKET ANALYSIS BY TARGET GROUP
    45. 6.45 INDIA MARKET ANALYSIS BY TREATMENT TYPE
    46. 6.46 INDIA MARKET ANALYSIS BY PROCEDURE CATEGORY
    47. 6.47 INDIA MARKET ANALYSIS BY SKIN TYPE
    48. 6.48 INDIA MARKET ANALYSIS BY TARGET GROUP
    49. 6.49 JAPAN MARKET ANALYSIS BY TREATMENT TYPE
    50. 6.50 JAPAN MARKET ANALYSIS BY PROCEDURE CATEGORY
    51. 6.51 JAPAN MARKET ANALYSIS BY SKIN TYPE
    52. 6.52 JAPAN MARKET ANALYSIS BY TARGET GROUP
    53. 6.53 SOUTH KOREA MARKET ANALYSIS BY TREATMENT TYPE
    54. 6.54 SOUTH KOREA MARKET ANALYSIS BY PROCEDURE CATEGORY
    55. 6.55 SOUTH KOREA MARKET ANALYSIS BY SKIN TYPE
    56. 6.56 SOUTH KOREA MARKET ANALYSIS BY TARGET GROUP
    57. 6.57 MALAYSIA MARKET ANALYSIS BY TREATMENT TYPE
    58. 6.58 MALAYSIA MARKET ANALYSIS BY PROCEDURE CATEGORY
    59. 6.59 MALAYSIA MARKET ANALYSIS BY SKIN TYPE
    60. 6.60 MALAYSIA MARKET ANALYSIS BY TARGET GROUP
    61. 6.61 THAILAND MARKET ANALYSIS BY TREATMENT TYPE
    62. 6.62 THAILAND MARKET ANALYSIS BY PROCEDURE CATEGORY
    63. 6.63 THAILAND MARKET ANALYSIS BY SKIN TYPE
    64. 6.64 THAILAND MARKET ANALYSIS BY TARGET GROUP
    65. 6.65 INDONESIA MARKET ANALYSIS BY TREATMENT TYPE
    66. 6.66 INDONESIA MARKET ANALYSIS BY PROCEDURE CATEGORY
    67. 6.67 INDONESIA MARKET ANALYSIS BY SKIN TYPE
    68. 6.68 INDONESIA MARKET ANALYSIS BY TARGET GROUP
    69. 6.69 REST OF APAC MARKET ANALYSIS BY TREATMENT TYPE
    70. 6.70 REST OF APAC MARKET ANALYSIS BY PROCEDURE CATEGORY
    71. 6.71 REST OF APAC MARKET ANALYSIS BY SKIN TYPE
    72. 6.72 REST OF APAC MARKET ANALYSIS BY TARGET GROUP
    73. 6.73 SOUTH AMERICA MARKET ANALYSIS
    74. 6.74 BRAZIL MARKET ANALYSIS BY TREATMENT TYPE
    75. 6.75 BRAZIL MARKET ANALYSIS BY PROCEDURE CATEGORY
    76. 6.76 BRAZIL MARKET ANALYSIS BY SKIN TYPE
    77. 6.77 BRAZIL MARKET ANALYSIS BY TARGET GROUP
    78. 6.78 MEXICO MARKET ANALYSIS BY TREATMENT TYPE
    79. 6.79 MEXICO MARKET ANALYSIS BY PROCEDURE CATEGORY
    80. 6.80 MEXICO MARKET ANALYSIS BY SKIN TYPE
    81. 6.81 MEXICO MARKET ANALYSIS BY TARGET GROUP
    82. 6.82 ARGENTINA MARKET ANALYSIS BY TREATMENT TYPE
    83. 6.83 ARGENTINA MARKET ANALYSIS BY PROCEDURE CATEGORY
    84. 6.84 ARGENTINA MARKET ANALYSIS BY SKIN TYPE
    85. 6.85 ARGENTINA MARKET ANALYSIS BY TARGET GROUP
    86. 6.86 REST OF SOUTH AMERICA MARKET ANALYSIS BY TREATMENT TYPE
    87. 6.87 REST OF SOUTH AMERICA MARKET ANALYSIS BY PROCEDURE CATEGORY
    88. 6.88 REST OF SOUTH AMERICA MARKET ANALYSIS BY SKIN TYPE
    89. 6.89 REST OF SOUTH AMERICA MARKET ANALYSIS BY TARGET GROUP
    90. 6.90 MEA MARKET ANALYSIS
    91. 6.91 GCC COUNTRIES MARKET ANALYSIS BY TREATMENT TYPE
    92. 6.92 GCC COUNTRIES MARKET ANALYSIS BY PROCEDURE CATEGORY
    93. 6.93 GCC COUNTRIES MARKET ANALYSIS BY SKIN TYPE
    94. 6.94 GCC COUNTRIES MARKET ANALYSIS BY TARGET GROUP
    95. 6.95 SOUTH AFRICA MARKET ANALYSIS BY TREATMENT TYPE
    96. 6.96 SOUTH AFRICA MARKET ANALYSIS BY PROCEDURE CATEGORY
    97. 6.97 SOUTH AFRICA MARKET ANALYSIS BY SKIN TYPE
    98. 6.98 SOUTH AFRICA MARKET ANALYSIS BY TARGET GROUP
    99. 6.99 REST OF MEA MARKET ANALYSIS BY TREATMENT TYPE
    100. 6.100 REST OF MEA MARKET ANALYSIS BY PROCEDURE CATEGORY
    101. 6.101 REST OF MEA MARKET ANALYSIS BY SKIN TYPE
    102. 6.102 REST OF MEA MARKET ANALYSIS BY TARGET GROUP
    103. 6.103 KEY BUYING CRITERIA OF HEALTHCARE
    104. 6.104 RESEARCH PROCESS OF MRFR
    105. 6.105 DRO ANALYSIS OF HEALTHCARE
    106. 6.106 DRIVERS IMPACT ANALYSIS: HEALTHCARE
    107. 6.107 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
    108. 6.108 SUPPLY / VALUE CHAIN: HEALTHCARE
    109. 6.109 HEALTHCARE, BY TREATMENT TYPE, 2024 (% SHARE)
    110. 6.110 HEALTHCARE, BY TREATMENT TYPE, 2024 TO 2035 (USD Billion)
    111. 6.111 HEALTHCARE, BY PROCEDURE CATEGORY, 2024 (% SHARE)
    112. 6.112 HEALTHCARE, BY PROCEDURE CATEGORY, 2024 TO 2035 (USD Billion)
    113. 6.113 HEALTHCARE, BY SKIN TYPE, 2024 (% SHARE)
    114. 6.114 HEALTHCARE, BY SKIN TYPE, 2024 TO 2035 (USD Billion)
    115. 6.115 HEALTHCARE, BY TARGET GROUP, 2024 (% SHARE)
    116. 6.116 HEALTHCARE, BY TARGET GROUP, 2024 TO 2035 (USD Billion)
    117. 6.117 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 North America MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY TREATMENT TYPE, 2025-2035 (USD Billion)
      2. 7.2.2 BY PROCEDURE CATEGORY, 2025-2035 (USD Billion)
      3. 7.2.3 BY SKIN TYPE, 2025-2035 (USD Billion)
      4. 7.2.4 BY TARGET GROUP, 2025-2035 (USD Billion)
    2. 7.3 US MARKET SIZE ESTIMATES; FORECAST
      1. 7.3.1 BY TREATMENT TYPE, 2025-2035 (USD Billion)
      2. 7.3.2 BY PROCEDURE CATEGORY, 2025-2035 (USD Billion)
      3. 7.3.3 BY SKIN TYPE, 2025-2035 (USD Billion)
      4. 7.3.4 BY TARGET GROUP, 2025-2035 (USD Billion)
    3. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST
      1. 7.4.1 BY TREATMENT TYPE, 2025-2035 (USD Billion)
      2. 7.4.2 BY PROCEDURE CATEGORY, 2025-2035 (USD Billion)
      3. 7.4.3 BY SKIN TYPE, 2025-2035 (USD Billion)
      4. 7.4.4 BY TARGET GROUP, 2025-2035 (USD Billion)
    4. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST
      1. 7.5.1 BY TREATMENT TYPE, 2025-2035 (USD Billion)
      2. 7.5.2 BY PROCEDURE CATEGORY, 2025-2035 (USD Billion)
      3. 7.5.3 BY SKIN TYPE, 2025-2035 (USD Billion)
      4. 7.5.4 BY TARGET GROUP, 2025-2035 (USD Billion)
    5. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST
      1. 7.6.1 BY TREATMENT TYPE, 2025-2035 (USD Billion)
      2. 7.6.2 BY PROCEDURE CATEGORY, 2025-2035 (USD Billion)
      3. 7.6.3 BY SKIN TYPE, 2025-2035 (USD Billion)
      4. 7.6.4 BY TARGET GROUP, 2025-2035 (USD Billion)
    6. 7.7 UK MARKET SIZE ESTIMATES; FORECAST
      1. 7.7.1 BY TREATMENT TYPE, 2025-2035 (USD Billion)
      2. 7.7.2 BY PROCEDURE CATEGORY, 2025-2035 (USD Billion)
      3. 7.7.3 BY SKIN TYPE, 2025-2035 (USD Billion)
      4. 7.7.4 BY TARGET GROUP, 2025-2035 (USD Billion)
    7. 7.8 France MARKET SIZE ESTIMATES; FORECAST
      1. 7.8.1 BY TREATMENT TYPE, 2025-2035 (USD Billion)
      2. 7.8.2 BY PROCEDURE CATEGORY, 2025-2035 (USD Billion)
      3. 7.8.3 BY SKIN TYPE, 2025-2035 (USD Billion)
      4. 7.8.4 BY TARGET GROUP, 2025-2035 (USD Billion)
    8. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST
      1. 7.9.1 BY TREATMENT TYPE, 2025-2035 (USD Billion)
      2. 7.9.2 BY PROCEDURE CATEGORY, 2025-2035 (USD Billion)
      3. 7.9.3 BY SKIN TYPE, 2025-2035 (USD Billion)
      4. 7.9.4 BY TARGET GROUP, 2025-2035 (USD Billion)
    9. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST
      1. 7.10.1 BY TREATMENT TYPE, 2025-2035 (USD Billion)
      2. 7.10.2 BY PROCEDURE CATEGORY, 2025-2035 (USD Billion)
      3. 7.10.3 BY SKIN TYPE, 2025-2035 (USD Billion)
      4. 7.10.4 BY TARGET GROUP, 2025-2035 (USD Billion)
    10. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST
      1. 7.11.1 BY TREATMENT TYPE, 2025-2035 (USD Billion)
      2. 7.11.2 BY PROCEDURE CATEGORY, 2025-2035 (USD Billion)
      3. 7.11.3 BY SKIN TYPE, 2025-2035 (USD Billion)
      4. 7.11.4 BY TARGET GROUP, 2025-2035 (USD Billion)
    11. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
      1. 7.12.1 BY TREATMENT TYPE, 2025-2035 (USD Billion)
      2. 7.12.2 BY PROCEDURE CATEGORY, 2025-2035 (USD Billion)
      3. 7.12.3 BY SKIN TYPE, 2025-2035 (USD Billion)
      4. 7.12.4 BY TARGET GROUP, 2025-2035 (USD Billion)
    12. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST
      1. 7.13.1 BY TREATMENT TYPE, 2025-2035 (USD Billion)
      2. 7.13.2 BY PROCEDURE CATEGORY, 2025-2035 (USD Billion)
      3. 7.13.3 BY SKIN TYPE, 2025-2035 (USD Billion)
      4. 7.13.4 BY TARGET GROUP, 2025-2035 (USD Billion)
    13. 7.14 China MARKET SIZE ESTIMATES; FORECAST
      1. 7.14.1 BY TREATMENT TYPE, 2025-2035 (USD Billion)
      2. 7.14.2 BY PROCEDURE CATEGORY, 2025-2035 (USD Billion)
      3. 7.14.3 BY SKIN TYPE, 2025-2035 (USD Billion)
      4. 7.14.4 BY TARGET GROUP, 2025-2035 (USD Billion)
    14. 7.15 India MARKET SIZE ESTIMATES; FORECAST
      1. 7.15.1 BY TREATMENT TYPE, 2025-2035 (USD Billion)
      2. 7.15.2 BY PROCEDURE CATEGORY, 2025-2035 (USD Billion)
      3. 7.15.3 BY SKIN TYPE, 2025-2035 (USD Billion)
      4. 7.15.4 BY TARGET GROUP, 2025-2035 (USD Billion)
    15. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST
      1. 7.16.1 BY TREATMENT TYPE, 2025-2035 (USD Billion)
      2. 7.16.2 BY PROCEDURE CATEGORY, 2025-2035 (USD Billion)
      3. 7.16.3 BY SKIN TYPE, 2025-2035 (USD Billion)
      4. 7.16.4 BY TARGET GROUP, 2025-2035 (USD Billion)
    16. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
      1. 7.17.1 BY TREATMENT TYPE, 2025-2035 (USD Billion)
      2. 7.17.2 BY PROCEDURE CATEGORY, 2025-2035 (USD Billion)
      3. 7.17.3 BY SKIN TYPE, 2025-2035 (USD Billion)
      4. 7.17.4 BY TARGET GROUP, 2025-2035 (USD Billion)
    17. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
      1. 7.18.1 BY TREATMENT TYPE, 2025-2035 (USD Billion)
      2. 7.18.2 BY PROCEDURE CATEGORY, 2025-2035 (USD Billion)
      3. 7.18.3 BY SKIN TYPE, 2025-2035 (USD Billion)
      4. 7.18.4 BY TARGET GROUP, 2025-2035 (USD Billion)
    18. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
      1. 7.19.1 BY TREATMENT TYPE, 2025-2035 (USD Billion)
      2. 7.19.2 BY PROCEDURE CATEGORY, 2025-2035 (USD Billion)
      3. 7.19.3 BY SKIN TYPE, 2025-2035 (USD Billion)
      4. 7.19.4 BY TARGET GROUP, 2025-2035 (USD Billion)
    19. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
      1. 7.20.1 BY TREATMENT TYPE, 2025-2035 (USD Billion)
      2. 7.20.2 BY PROCEDURE CATEGORY, 2025-2035 (USD Billion)
      3. 7.20.3 BY SKIN TYPE, 2025-2035 (USD Billion)
      4. 7.20.4 BY TARGET GROUP, 2025-2035 (USD Billion)
    20. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
      1. 7.21.1 BY TREATMENT TYPE, 2025-2035 (USD Billion)
      2. 7.21.2 BY PROCEDURE CATEGORY, 2025-2035 (USD Billion)
      3. 7.21.3 BY SKIN TYPE, 2025-2035 (USD Billion)
      4. 7.21.4 BY TARGET GROUP, 2025-2035 (USD Billion)
    21. 7.22 South America MARKET SIZE ESTIMATES; FORECAST
      1. 7.22.1 BY TREATMENT TYPE, 2025-2035 (USD Billion)
      2. 7.22.2 BY PROCEDURE CATEGORY, 2025-2035 (USD Billion)
      3. 7.22.3 BY SKIN TYPE, 2025-2035 (USD Billion)
      4. 7.22.4 BY TARGET GROUP, 2025-2035 (USD Billion)
    22. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
      1. 7.23.1 BY TREATMENT TYPE, 2025-2035 (USD Billion)
      2. 7.23.2 BY PROCEDURE CATEGORY, 2025-2035 (USD Billion)
      3. 7.23.3 BY SKIN TYPE, 2025-2035 (USD Billion)
      4. 7.23.4 BY TARGET GROUP, 2025-2035 (USD Billion)
    23. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
      1. 7.24.1 BY TREATMENT TYPE, 2025-2035 (USD Billion)
      2. 7.24.2 BY PROCEDURE CATEGORY, 2025-2035 (USD Billion)
      3. 7.24.3 BY SKIN TYPE, 2025-2035 (USD Billion)
      4. 7.24.4 BY TARGET GROUP, 2025-2035 (USD Billion)
    24. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
      1. 7.25.1 BY TREATMENT TYPE, 2025-2035 (USD Billion)
      2. 7.25.2 BY PROCEDURE CATEGORY, 2025-2035 (USD Billion)
      3. 7.25.3 BY SKIN TYPE, 2025-2035 (USD Billion)
      4. 7.25.4 BY TARGET GROUP, 2025-2035 (USD Billion)
    25. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
      1. 7.26.1 BY TREATMENT TYPE, 2025-2035 (USD Billion)
      2. 7.26.2 BY PROCEDURE CATEGORY, 2025-2035 (USD Billion)
      3. 7.26.3 BY SKIN TYPE, 2025-2035 (USD Billion)
      4. 7.26.4 BY TARGET GROUP, 2025-2035 (USD Billion)
    26. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST
      1. 7.27.1 BY TREATMENT TYPE, 2025-2035 (USD Billion)
      2. 7.27.2 BY PROCEDURE CATEGORY, 2025-2035 (USD Billion)
      3. 7.27.3 BY SKIN TYPE, 2025-2035 (USD Billion)
      4. 7.27.4 BY TARGET GROUP, 2025-2035 (USD Billion)
    27. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
      1. 7.28.1 BY TREATMENT TYPE, 2025-2035 (USD Billion)
      2. 7.28.2 BY PROCEDURE CATEGORY, 2025-2035 (USD Billion)
      3. 7.28.3 BY SKIN TYPE, 2025-2035 (USD Billion)
      4. 7.28.4 BY TARGET GROUP, 2025-2035 (USD Billion)
    28. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
      1. 7.29.1 BY TREATMENT TYPE, 2025-2035 (USD Billion)
      2. 7.29.2 BY PROCEDURE CATEGORY, 2025-2035 (USD Billion)
      3. 7.29.3 BY SKIN TYPE, 2025-2035 (USD Billion)
      4. 7.29.4 BY TARGET GROUP, 2025-2035 (USD Billion)
    29. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
      1. 7.30.1 BY TREATMENT TYPE, 2025-2035 (USD Billion)
      2. 7.30.2 BY PROCEDURE CATEGORY, 2025-2035 (USD Billion)
      3. 7.30.3 BY SKIN TYPE, 2025-2035 (USD Billion)
      4. 7.30.4 BY TARGET GROUP, 2025-2035 (USD Billion)
    30. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.31.1
    1. 7.32 ACQUISITION/PARTNERSHIP
  10. 7.32.1

Healthcare Market Segmentation

Healthcare By Treatment Type (USD Billion, 2025-2035)

  • Surgical Procedures
  • Non-Surgical Procedures
  • Injectables
  • Laser Treatments

Healthcare By Procedure Category (USD Billion, 2025-2035)

  • Facelift
  • Botox Injections
  • Dermal Fillers
  • Chemical Peels

Healthcare By Skin Type (USD Billion, 2025-2035)

  • Aging Skin
  • Dry Skin
  • Oily Skin
  • Combination Skin

Healthcare By Target Group (USD Billion, 2025-2035)

  • Men
  • Women
  • Aging Population